TORONTO, Sept. 5, 2013 /CNW/ -01 Communique Laboratory Inc. (ONE:TSX) today announced results for its
third quarter 2013 which ended July 31, 2013. The loss for the third
quarter 2013 was $584,941 compared to $697,693 in 2012 a decrease of
$112,852. Excluding non-cash expenses for stock-based compensation and
depreciation the adjusted loss for the third quarter 2013 was $235,187
compared to $271,456 in 2012. The Company completed the quarter with
$3,566,150 of cash and cash equivalents.
"The cash operating expenses to run our business, excluding the costs
associated with intellectual property revenue, were reduced for the
third quarter to approximately $400,000," said Andrew Cheung, President
and CEO for 01 Communique. "Reducing expenses to this level still
allowed us to continue with development of a competitive product
offering and continue to vigorously defend our intellectual property
rights against LogMeIn Inc. and Citrix Systems Inc. Going forward, we
will continue with these two main objectives."
Citrix Litigation Update -
On May 8, 2013 a hearing took place in front of the United States Patent
and Trademark Office's ("USPTO") Patent Trial and Appeal Board ("PTAB")
in respect of the Citrix Systems Inc. ("Citrix") appeal of the results
of the inter partes re-examination of our United States patent number
6,928,479 ("'479 Patent") which Citrix had requested. We are now
waiting for the PTAB to render their written report. We are confident
in the merits of our case and believe the PTAB will uphold the validity
of the '479 Patent. Previously the jury in the LogMeIn lawsuit upheld
the validity of the 479 Patent as did the USPTO patent examiner in the
Right of Appeal Notice ("RAN") and the Examiner's Report filed last
year as part of the appeal process.
LogMeIn Appeal Update -
We disagree with the jury's finding of non-infringement in the LogMeIn
Inc. ("LogMeIn") case and, as previously announced, on June 26, 2013 we
filed a notice of appeal with the United States Court of Appeal for the
Federal Circuit (Appeal Nos. 2013-1479). LogMeIn has filed a cross
appeal, (Case No. 2013-1525) in respect of the Court Order concluding
that our patent was valid and enforceable. Their cross appeal has been
consolidated with our appeal. As part of the appeal process we filed
our Appeal Brief with the Federal Circuit on August 26, 2013. We are
confident in the merits of our appeal.
Financial Highlights -
-
Revenue for the third quarter 2013 was $729,860 compared to $582,440 for
the same period in 2012, an increase of $147,420 primarily a result of
increased revenue from licensing intellectual property. Revenue from
intellectual property for the third quarter 2013 was $669,500 (2012 -
$500,000).
-
Cash operating expenses which exclude stock-based compensation and
depreciation were $965,254 for the third quarter 2013 compared to
$857,185 in 2012 an increase of $108,069 primarily a result of an
increase in expenses relating to intellectual property revenue.
-
Excluding expenses related to intellectual property revenue of $568,442
(2012 - $425,000), cash operating expenses for the third quarter 2013
were $396,812 compared to 2012 of $432,185 a reduction of $35,373.
The Toronto Stock Exchange has not reviewed and does not accept
responsibility for the adequacy or the accuracy of this release.
About 01 Communique
Established in 1992, 01 Communique Laboratory Inc. (TSX: ONE) offers a
suite of remote access services designed for small-medium sized
business, mobile professionals and IT service providers. 01's software
as a service offerings are deployed on-demand and include functionality
enabling on-line meetings, remote computing and IT support. 01's suite
of products includes its remote access offering I'm InTouch (www.imintouch.com), its online meeting offering (www.imintouchmeeting.com) and its remote support offering I'm OnCall (www.imoncall.com ) products are protected in the U.S.A. by its patents #6928479 /
#6938076 / #8234701 and in Canada by its patent #2309398 and Japan by
its patent #4,875,094. For more information, visit www.01com.com or call (905) 795-888 or (800) 668-2185 (North America only).
Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking"
statements which involve known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or
achievements of the company, or industry results, to be materially
different from any future results, performance or achievements
expressed or implied by such forward-looking statements. When used in
this news release, such statements use such words as "may", "will",
"expect", "believe", "plan", "intend", "are confident" and other
similar terminology. These statements reflect current expectations
regarding future events and operating performance and speak only as of
the date of this news release. Forward-looking statements involve
significant risks and uncertainties, should not be read as guarantees
of future performance or results, and will not necessarily be accurate
indications of whether or not such results will be achieved. A number
of factors could cause actual results to differ materially from the
results discussed in the forward-looking statements, including, but not
limited to, the factors discussed under "Risk Factors" in the company's
Annual Information Form filed on SEDAR. Although the forward-looking
statements contained in this news release are based upon what
management of the Company believes are reasonable assumptions, the
company cannot assure investors that actual results will be consistent
with these forward looking statements. These forward-looking statements
are made as of the date of this news release, and the company assumes
no obligation to update or revise them to reflect new events or
circumstances.
01 Communique Laboratory Inc. |
SELECTED FINANCIAL INFORMATION |
Consolidated Statements of Financial Position |
|
|
|
| 31-Jul-13 | 31-Oct-12 |
|
|
|
Assets
|
|
|
Current assets:
|
|
|
|
Cash and cash equivalents
|
$ 3,566,150
|
$ 4,547,375
|
|
Accounts receivable
|
41,837
|
282,981
|
|
Prepaid expenses and other assets
|
69,080
|
35,676
|
|
3,677,067
|
4,866,032
|
|
|
|
Property and equipment
|
17,961
|
17,261
|
|
$ 3,695,028
|
$ 4,883,293
|
|
|
|
Liabilities and Shareholders' Equity
|
|
|
|
|
|
Current liabilities:
|
|
|
|
Accounts payable and accrued liabilities
|
$ 1,117,028
|
$ 407,770
|
|
Deferred revenue
|
25,916
|
34,596
|
|
1,142,944
|
442,366
|
|
|
|
Shareholders' equity:
|
|
|
|
Share capital
|
39,997,277
|
39,566,407
|
|
Contributed surplus
|
4,384,066
|
3,752,710
|
|
Agent options
|
111,780
|
248,400
|
|
Deficit
|
(41,941,039)
|
(39,126,590)
|
|
2,552,084
|
4,440,927
|
|
$ 3,695,028
|
$ 4,883,293
|
01 Communique Laboratory Inc. |
SELECTED FINANCIAL INFORMATION |
Consolidated Statements of Operations and Comprehensive Income |
For the 3 and 9 month periods ended July 31, 2013 and 2012 |
|
| for the 3 months ending |
| for the 9 months ending |
| 31-Jul-13 | 31-Jul-12 |
| 31-Jul-13 | 31-Jul-12 |
Revenue
| $729,860 | $582,440 |
| $1,096,299 | $753,812 |
Cost of revenue
|
-
|
38
|
|
-
|
261
|
|
729,860
|
582,402
|
|
1,096,299
|
753,551
|
|
|
|
|
|
|
Expenses (income)
|
|
|
|
|
|
Selling, general and administrative
|
530,394
|
614,430
|
|
1,306,409
|
1,622,145
|
Patent enforcement & re-examination expenses
|
568,442
|
425,000
|
|
1,965,542
|
425,000
|
Research and development
|
216,172
|
244,092
|
|
657,864
|
737,567
|
Interest
|
(207)
|
(3,327)
|
|
(19,067)
|
(12,221)
|
|
1,314,801
|
1,280,195
|
|
3,910,748
|
2,772,491
|
|
|
|
|
|
|
Loss for the period and comprehensive loss
|
(584,941)
|
(697,793)
|
|
(2,814,449)
|
(2,018,940)
|
|
|
|
|
|
|
Loss per common share
|
|
|
|
|
|
Basic
|
$ (0.009)
|
$ (0.012)
|
|
$ (0.043)
|
$ (0.033)
|
Diluted
|
$ (0.009)
|
$ (0.012)
|
|
$ (0.043)
|
$ (0.033)
|
|
|
|
|
|
|
Weighted average number of common shares
|
|
|
|
|
|
Basic
|
65,203,807
|
60,636,502
|
|
65,080,948
|
60,428,803
|
Diluted
|
65,203,807
|
60,636,502
|
|
65,080,948
|
60,428,803
|
01 Communique Laboratory Inc. |
SELECTED FINANCIAL INFORMATION |
Consolidated Statements of Cash Flows |
For the 3 and 9 month periods ended July 31, 2013 and 2012 |
|
|
|
|
|
|
|
three months ending
|
|
|
nine months ending
|
|
| 31-Jul-13 | 31-Jul-12 |
| 31-Jul-13 | 31-Jul-12 |
Cash provided by (used in):
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities:
|
|
|
|
|
|
Loss for the period
|
$ (584,941)
|
$ (697,793)
|
|
$ (2,814,449)
|
$ (2,018,940)
|
Adjustments to reconcile the loss
for the period to net cash flows from
|
|
|
|
|
|
operating activities:
|
|
|
|
|
|
Depreciation
|
1,754
|
1,538
|
|
5,657
|
7,099
|
Stock-based compensation
|
348,000
|
424,799
|
|
631,356
|
925,507
|
Interest income
|
(207)
|
(3,327)
|
|
(19,067)
|
(12,221)
|
Change in non-cash working capital
|
(1,303)
|
87,633
|
|
908,318
|
(217,898)
|
|
(236,697)
|
(187,150)
|
|
(1,288,185)
|
(1,316,453)
|
Interest income received
|
207
|
3,327
|
|
19,067
|
12,221
|
|
(236,490)
|
(183,823)
|
|
(1,269,118)
|
(1,304,232)
|
|
|
|
|
|
|
Financing activities:
|
|
|
|
|
|
Issue of common shares
|
-
|
275,450
|
|
294,250
|
375,450
|
Investing activities:
|
|
|
|
|
|
Purchase of capital assets
|
(572)
|
(665)
|
|
(6,357)
|
(1,455)
|
Increase (decrease) in cash
|
(237,062)
|
90,962
|
|
(981,225)
|
(930,237)
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
3,803,212
|
2,100,218
|
|
4,547,375
|
3,121,417
|
Cash and cash equivalents, end of period
|
$ 3,566,150
|
$ 2,191,180
|
|
$ 3,566,150
|
$ 2,191,180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SOURCE: 01 Communique Laboratory Inc.
<p> <b>INVESTOR CONTACT:</b><br/> Brian Stringer<br/> Chief Financial Officer<br/> 01 Communique<br/> (905) 795-2888 x204<br/> <a href="mailto:brian.stringer@01com.com">brian.stringer@01com.com</a> </p>